BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19038405)

  • 1. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
    Popp J; Bacher M; Kölsch H; Noelker C; Deuster O; Dodel R; Jessen F
    J Psychiatr Res; 2009 May; 43(8):749-53. PubMed ID: 19038405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
    Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
    Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
    Immunol Lett; 2008 May; 117(2):198-202. PubMed ID: 18367253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
    Lee KS; Chung JH; Lee KH; Shin MJ; Oh BH; Hong CH
    Immunol Lett; 2008 Dec; 121(2):105-9. PubMed ID: 18930766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
    Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
    Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients.
    Chen LC; Lei HY; Liu CC; Shiesh SC; Chen SH; Liu HS; Lin YS; Wang ST; Shyu HW; Yeh TM
    Am J Trop Med Hyg; 2006 Jan; 74(1):142-7. PubMed ID: 16407359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
    Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
    Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
    Zhang W; Yue B; Wang GQ; Lu SL
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M; Paraskevas GP; Kapaki E; Nikolaou C; Zoga M; Rombos A; Tsoutsou A; Vassilopoulos D D
    J Neurol Sci; 2006 Nov; 249(2):110-4. PubMed ID: 16843497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF cortisol in Alzheimer's disease and mild cognitive impairment.
    Popp J; Schaper K; Kölsch H; Cvetanovska G; Rommel F; Klingmüller D; Dodel R; Wüllner U; Jessen F
    Neurobiol Aging; 2009 Mar; 30(3):498-500. PubMed ID: 17716786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
    Noh SU; Cho EA; Kim HO; Park YM
    Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum levels of pro-inflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them].
    Yu LN; Yang XS; Hua Z; Xie W
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):469-71. PubMed ID: 19567096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
    Oikonomidi A; Tautvydaitė D; Gholamrezaee MM; Henry H; Bacher M; Popp J
    J Alzheimers Dis; 2017; 60(1):273-281. PubMed ID: 28826184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
    Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
    Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
    Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P
    Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.
    Zhong Z; Ewers M; Teipel S; Bürger K; Wallin A; Blennow K; He P; McAllister C; Hampel H; Shen Y
    Arch Gen Psychiatry; 2007 Jun; 64(6):718-26. PubMed ID: 17548753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
    Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment.
    Bossù P; Ciaramella A; Salani F; Bizzoni F; Varsi E; Di Iulio F; Giubilei F; Gianni W; Trequattrini A; Moro ML; Bernardini S; Caltagirone C; Spalletta G
    Brain Behav Immun; 2008 May; 22(4):487-92. PubMed ID: 17988833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.